TNGX Sale Disclosure
Crystal Adam · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$25.29K
Crystal Adam President, R&d
TNGX
Tango Therapeutics
TNGX
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
TNGX daily price context
Close on/before transaction
$21.76
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,100 shares @ $22.99
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-447915
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$126.66K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tango Therapeutics, Inc. TNGX | Exercise | Nov 2, 2026 | $14.55K |
| Tango Therapeutics, Inc. TNGX | Exercise | Nov 2, 2026 | $0 |
| Tango Therapeutics, Inc. TNGX | Sale | Nov 2, 2026 | $86.82K |
| Tango Therapeutics, Inc. TNGX Current | Sale | Nov 2, 2026 | $25.29K |